September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Paolo Tarantino: No statistical improvement in OS with the Trop2 ADC SG vs TPC in met urothelial cancer
Feb 14, 2025, 09:48

Paolo Tarantino: No statistical improvement in OS with the Trop2 ADC SG vs TPC in met urothelial cancer

Paolo Tarantino, Advanced research fellow at Dana-Farber Cancer Institute, shared a paper Tom Powles and his colleagues authored on X:

“TROPiCS-04 trial out on Annals of Oncology: no statistical improvement in OS with the Trop2 ADC SG vs TPC in met urothelial cancer, with higher rate of G5 AEs with SG. Led to the withdrawal of SG approval for mUC. No association between Trop2 exp and SG activity.”

Sacituzumab govitecan in advanced urothelial carcinoma: TROPiCS-04, a phase III randomized trial

Authors: Thomas Powles et al.

Paolo Tarantino